EPS (diluted) · 2011–2015
Neogenomics diluted EPS
−0.04−0.06 · FY2015
Neogenomics (NEO) reported −0.04 in diluted EPS for fiscal 2015, −0.06 from the year before.
EPS (diluted) — Diluted earnings per share is net income divided by the share count after every option and convertible is counted as if exercised. It is the conservative version of EPS.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
EPS (diluted) at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neogenomics diluted EPS |url=https://companiesranked.com/en/company/neogenomics/eps |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neogenomics diluted EPS. CompaniesRanked. https://companiesranked.com/en/company/neogenomics/epsBibTeX
@misc{companiesranked-en-company-neogenomics-eps-2026,
author = {{CompaniesRanked}},
title = {{Neogenomics diluted EPS}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neogenomics/eps}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.